Webinar: Operational Excellence in Bio/Pharmaceutical Manufacturing

Sponsored by: North Carolina Biotech Center

Focused on:

    Date: 7th April

    Days old: 5053

    Time: 15:00 BST

    Watch Now for FREE

    Maximizing Efficiency in your Manufacturing Facility

    How can large biomanufacturing facilities increase efficiency while reducing overhead?

    What factors play the largest role in achieving operational excellence in biopharmaceutical manufacturing?

    For biotechnology companies maturing and progressing from research and development into manufacturing, decisions must be made whether to outsource production or manufacture in-house; which is superior?

    For those expanding and already with products in manufacture, what factors are important for operational excellence in a new facility?

    Our distinguished panel of experts will come together to discuss these questions, and offer solutions from their own experiences.

    Presented by

    Phil Priest,

    VP, Site Director, GSK

    Phil Priest, GSK, VP, Site Director, Zebulon, North Carolina Phil Priest is VP and Head of the GlaxoSmithKline (GSK) North American Pharma supply facility in Zebulon North Carolina. Prior to this Phil was the VP and Head of Strategy for the manufacturing division of GSK. Since joining GSK in 1999, Phil has held a number of leadership roles in the manufacturing division including: Head of Logistics for GSK's International area (rest of world excluding US and Western Europe) managing GSK's distribution network through a team of regional directors based in five different continents. Phil led the team that created an import/export hub for GSK in Tianjin China, Dubai, Panama and in France serving North Africa. Prior to joining GSK Phil held a number of senior positions in manufacturing and Supply Chain for Albright and Wilson, an UK-headquartered global chemical company.

    Esther Alegria,

    VP, Manufacturing & GM, Biogen Idec

    Esther Alegria, Ph.D. is Vice President of Manufacturing and General Manager of Biogen Idec's Research Triangle Park, North Carolina two world-class biopharmaceutical manufacturing facilities. Under Esther's oversight, the Research Triangle Park, North Carolina facilities are also responsible for the production of novel new therapeutic drugs, currently at various stages of clinical development. Additionally, she brings approximately 20 years of experience in pharmaceutical & biopharmaceuticals with roles of increasing responsibility at Biogen Idec. Prior to assuming the Vice President, Manufacturing and General Manager role she served as Director of Manufacturing after being named Director of Quality Assurance/Quality Control. During her career at Wyeth she was a key player in the development and commercialization of blockbuster vaccines, and held positions of increasing responsibilities. Esther holds a Ph.D. in Chemistry from the University of Hawaii and an Executive Business Management certification from Harvard Business School.

    Louis Arp, MBA,

    General Manager, US Operations, Eisai Inc

    Louis Arp, General Manager, US Operations, of Eisai Inc's production and formulation R&D facility in Research Triangle Park, North Carolina.

    Download Slides

    Please login to download the slides

    Key Learning Objectives

    • Specific factors allowing for operational excellence in biomanufacturing
    • Pros/cons of R&D and manufacturing in different locations, including Europe vs. US
    • Whether or not these factors are similar in small molecule pharmaceutical manufacturing, and if they are the same whether you are outsourcing production or conducting it in-house
    • How North Carolina facilitates excellence in bio/pharmaceutical manufacturing

    Audience

    • VP Project Management - Renovo Ltd
    • Director Operations Management & Operational Excellence - Pfizer
    • Operational Excellence & Strategic Projects Manager - GSK
    • Managing Director - ATI Pharmed Co.
    • Vice President - Celerant Consulting
    • Site Director - GSK